Furthermore, EYA2 expression had a dramatic reduction in tumor growth in vivo both in subcutaneous and in orthotopic models, in two different pancreatic cancer cell lines and in multiple clones. This evidence concerns the gene EYA2 and pancreatic neoplasm.